Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from ...

President Trump's new executive order has drawn major attention to psychedelic treatments for mental health. Here's what ...

For centuries, healers knew what science is only now confirming: psilocybin is a powerful healing medicine. Could magic ...

The largest review of its kind found no evidence that medicinal cannabis treats depression. Researchers analyzed decades of ...

One in four psychiatric patients in Denmark are readmitted and that carries major personal and societal costs. But can we ...

Researchers from McGill University and Mila, Quebec’s artificial intelligence institute, brought together 89 experts from 17 ...

An international clinical trial led by researchers at the Center for Addiction and Mental Health (CAMH) and University of ...

When Jason Prinzo was diagnosed with depression, he was five years old. His father was an alcoholic and a drug addict who was ...

Experts recommended individualized MDD relapse prevention, including ECT tapering and pharmacotherapy based on risk profiles.

A landmark international clinical trial led by researchers at the Centre for Addiction and Mental Health (CAMH) and University of California San Diego School of Medicine, published in The Lancet ...

Esketamine first received FDA approval in 2019, but with an important restriction: it could only be used in combination with ...